Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma.
Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatology. 2015 Oct; 62(4):1111-21.